Literature DB >> 23333016

Preoperative radiotherapy and local excision of rectal cancer with immediate radical re-operation for poor responders: a prospective multicentre study.

Krzysztof Bujko1, Piotr Richter, Fraser M Smith, Wojciech Polkowski, Marek Szczepkowski, Andrzej Rutkowski, Adam Dziki, Lucyna Pietrzak, Milena Kołodziejczyk, Jerzy Kuśnierz, Tomasz Gach, Jan Kulig, Grzegorz Nawrocki, Jakub Radziszewski, Ryszard Wierzbicki, Teresa Kowalska, Wiktor Meissner, Andrzej Radkowski, Krzysztof Paprota, Marcin Polkowski, Anna Rychter.   

Abstract

PURPOSE: To assess local control after preoperative radiation and local excision and to determine an optimal radiotherapy regimen.
METHODS: Eighty-nine patients with G1-2 rectal adenocarcinoma <3-4 cm; unfavourable cT1N0 (23.6%), cT2N0 (62.9%) or borderline cT2/cT3N0 (13.5%) received 5 × 5 Gy plus 4 Gy boost (71.9%) or 55.8 Gy in 31 fractions with 5-FU and leucovorin (28.1%). Local excision (traditional technique 56.2%, transanal endoscopic microsurgery 41.6%, Kraske procedure 2.2%) was performed 6-8 weeks later. If patients were downstaged to ypT0-1 without unfavourable factors (good responders), this was deemed definitive treatment. Immediate conversion to radical surgery was recommended for remaining patients.
RESULTS: Good response to radiation was seen in 67.2% of patients in the short-course group and in 80.0% in the chemoradiation group, p = 0.30. Local recurrence at 2 years (median follow-up) in good responders was 11.8% in the short-course group and 6.2% in the chemoradiation group, p = 0.53. In the total group, a lower rate of local recurrence at 2 years was observed in elderly patients (>69 years, median value) when compared to the younger patients; 8.3% vs. 27.7%, Cox analysis hazard ratio 0.232, p = 0.016. A total of 18 patients initially managed with local excision required conversion to abdominal surgery but either refused it or were unfit. In this group, local recurrence at 2 years was 37.1%.
CONCLUSIONS: This study suggests an acceptable local recurrence rate after preoperative radiotherapy and local excision of small, radiosensitive tumours in elderly patients.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23333016     DOI: 10.1016/j.radonc.2012.12.005

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  24 in total

Review 1.  Oncological outcomes of local excision compared with radical surgery after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and meta-analysis.

Authors:  Irshad Shaikh; Alan Askari; Suzana Ourû; Janindra Warusavitarne; Thanos Athanasiou; Omar Faiz
Journal:  Int J Colorectal Dis       Date:  2014-11-04       Impact factor: 2.571

2.  Overexpression of nuclear β-catenin in rectal adenocarcinoma is associated with radioresistance.

Authors:  Lin Wang; Xiao-Mei Zhang; Zhen Li; Xi-Jun Liu; Jie Chai; Guang-Yong Zhang; Yu-Feng Cheng
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

Review 3.  Organ-Preserving Strategies for the Management of Near-Complete Responses in Rectal Cancer after Neoadjuvant Chemoradiation.

Authors:  Patricio B Lynn; Paul Strombom; Julio Garcia-Aguilar
Journal:  Clin Colon Rectal Surg       Date:  2017-11-27

Review 4.  Transanal Minimally Invasive Surgery.

Authors:  Earl V Thompson; Joshua I S Bleier
Journal:  Clin Colon Rectal Surg       Date:  2017-04

5.  Rectal sparing approach after preoperative radio- and/or chemotherapy (RESARCH) in patients with rectal cancer: a multicentre observational study.

Authors:  A Barina; A De Paoli; P Delrio; M Guerrieri; A Muratore; F Bianco; D Vespa; C Asteria; E Morpurgo; A Restivo; C Coco; U Pace; C Belluco; C Aschele; S Lonardi; V Valentini; G Mantello; I Maretto; P Del Bianco; A Perin; S Pucciarelli
Journal:  Tech Coloproctol       Date:  2017-07-28       Impact factor: 3.781

6.  Invite comment on Pucciarelli and Spolverato: The fate of the rectum after organ sparing approach to rectal cancer.

Authors:  S Pucciarelli; G Spolverato
Journal:  Tech Coloproctol       Date:  2019-10-10       Impact factor: 3.781

7.  Local excision in rectal cancer patients with major or complete clinical response after neoadjuvant therapy: a case-matched study.

Authors:  M Bushati; S Pucciarelli; N Gennaro; I Maretto; P Toppan; A Perin; E D L Urso; A Bagatella; G Spolverato
Journal:  Int J Colorectal Dis       Date:  2019-11-14       Impact factor: 2.571

Review 8.  Watchful Waiting after Radiochemotherapy in Rectal Cancer: When Is It Feasible?

Authors:  Cihan Gani; Andreas Kirschniak; Daniel Zips
Journal:  Visc Med       Date:  2019-03-27

9.  Neoadjuvant chemoradiation followed by transanal local excision for T2 rectal cancer confers equivalent survival benefit as traditional transabdominal resection.

Authors:  Oliver K Jawitz; Mohamed A Adam; Megan C Turner; Brian F Gilmore; John Migaly
Journal:  Surgery       Date:  2019-03-21       Impact factor: 3.982

10.  Preoperative chemoradiation with or without induction oxaliplatin plus 5-fluorouracil in locally advanced rectal cancer. Long-term outcome analysis.

Authors:  F A Calvo; C V Sole; J Serrano; E Del Valle; M Rodriguez; A Muñoz-Calero; J L García-Sabrido; P Garcia-Alfonso; I Peligros; E Alvarez
Journal:  Strahlenther Onkol       Date:  2013-12-06       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.